OVID
Ovid Therapeutics Inc
2.50$
+2.5%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Cash Flow
Ovid Therapeutics Inc (OVID) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -38 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.3 | -5.5 | -18 | -31 | -46 | -51 | -52 | 119 | -55 | -46 | -56 | -38 | |
| 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.3 | 0.3 | 0.2 | 1.4 | 1.6 | 0.6 | 0.3 | |
| 0.0 | 1.5 | 3.6 | 6.4 | 7.1 | 5.2 | 7.5 | 5.1 | 6.6 | 7.3 | 6.3 | 4.8 | |
| 0.0 | 5.9 | 3.6 | 32 | 7.1 | 5.2 | 7.3 | 5.1 | 6.6 | – | – | – | |
| 0.0 | 1.8 | 0.9 | 1.0 | -0.8 | 3.9 | 22 | -17 | -8.2 | 2.4 | -0.2 | -4.1 | |
| 0.0 | 0.1 | 0.2 | 0.0 | 0.4 | 0.2 | 0.4 | 0.2 | 1.4 | 0.1 | 0.1 | 0.0 | |
| 0.0 | -0.1 | -0.2 | 0.0 | -5.4 | -30 | 35 | -1.8 | -88 | -2.6 | 55 | -50 | |
| – | – | – | 0.0 | – | – | – | – | – | – | – | – | |
| 0.0 | 71 | 70 | 70 | 0.3 | 64 | 47 | 0.9 | 0.2 | – | – | – | |
| 0.1 | – | – | – | – | – | – | – | – | – | – | – | |
| 6.7 | 71 | 0.0 | 67 | 0.3 | 87 | 47 | 0.9 | 0.2 | 31 | 0.6 | 75 | |
| 6.5 | 65 | -18 | 35 | -51 | 5.4 | 30 | 118 | -143 | -18 | -0.7 | -13 | |
| -0.3 | -5.5 | -18 | -32 | -46 | -51 | -52 | 118 | -57 | -46 | -56 | -38 |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.